Phathom Pharmaceuticals Overview
Phathom Pharmaceuticals Target Price
Analysts' 12-month price predictions for PHAT.
Share Price
$10.64
Average Target Price
$18.00
69.2% upside
69.2% upside1 analysts in the last 4 months
High: $18 | Low: $18
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-07 | Guggenheim | $18 | 69.2% upside |  |
| 2024-08-08 | Goldman SachsPaul Choi | $12 | 12.8% upside | |
| 2024-07-19 | H.C. WainwrightMatthew Caufield | $28 | 163.2% upside | |
| 2024-05-02 | Stifel NicolausAnnabel Samimy | $24 | 125.6% upside | |
| 2024-01-05 | NeedhamJoseph Stringer | $26 | 144.4% upside | |
| 2023-01-04 | BMO Capital | $35 | 228.9% upside | |
| 2023-01-04 | Needham | $25 | 135% upside | |
| 2022-11-14 | BMO Capital | $38 | 257.1% upside | |
| 2022-11-11 | Guggenheim | $30 | 182% upside | |